(UPDATE) Daratumumab
Elotuzumab
Teclistamab-cqyv
The Leukemia and Lymphoma Society
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Virtual Reimbursement Resource Room
International Myeloma Foundation (IMF)